Literature DB >> 23020870

Correlation of metabolic syndrome with urinary stone composition.

Sung Tae Cho1, Seung Il Jung, Soon Chul Myung, Tae Hyoung Kim.   

Abstract

OBJECTIVE: To determine the correlation between metabolic syndrome and the distribution of stone components in patients with urolithiasis.
METHODS: Between January 2007 and December 2010, renal or ureteral stones were collected from 712 patients (432 males, 280 females) who underwent surgical intervention at three hospitals in South Korea. Metabolic syndrome was defined according to the latest definition of the International Diabetes Federation, using ethnicity- and sex-specific cut-off values for central obesity. Patients were assessed by factors used in metabolic syndrome. All urinary stones were analyzed using infrared spectrophotometry and categorized according to their main component.
RESULTS: The patients' mean age was 55.9 years (range 19-93 years). Of the 712 patients, 347 (48.7%; 205 males, 142 females) had a diagnosis of metabolic syndrome. Calcium oxalate (71.5%), uric acid (15.3%), carbonate apatite (8.0%) and struvite (4.1%) calculi were found as the main stone components. Overall, the proportion of uric acid calculi was markedly higher in patients with rather than without metabolic syndrome (19.6 vs 11.2%; P=0.002). However, the proportion of calcium oxalate, carbonate apatite and struvite calculi did not differ between the two groups. The multivariable-adjusted odds ratio for uric acid calculi according to the metabolic syndrome components indicated that the presence of metabolic syndrome was associated with a 93% increased odds ratio of uric acid calculi compared with the absence of metabolic syndrome. Impaired fasting glucose and hypertriglyceridemia were independent risk factors for uric acid calculi.
CONCLUSIONS: Metabolic syndrome is associated with a significantly increased risk of uric acid calculi development, especially those with impaired fasting glucose and hypertriglyceridemia.
© 2012 The Japanese Urological Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23020870     DOI: 10.1111/j.1442-2042.2012.03131.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  31 in total

Review 1.  Urolithiasis--an interdisciplinary diagnostic, therapeutic and secondary preventive challenge.

Authors:  Christian Fisang; Ralf Anding; Stefan C Müller; Stefan Latz; Norbert Laube
Journal:  Dtsch Arztebl Int       Date:  2015-02-06       Impact factor: 5.594

2.  Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers.

Authors:  Wonngarm Kittanamongkolchai; Kristin C Mara; Ramila A Mehta; Lisa E Vaughan; Aleksandar Denic; John J Knoedler; Felicity T Enders; John C Lieske; Andrew D Rule
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-01       Impact factor: 8.237

3.  Body fat content and distribution and urinary risk factors for nephrolithiasis.

Authors:  Federica Pigna; Khashayar Sakhaee; Beverley Adams-Huet; Naim M Maalouf
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 8.237

Review 4.  Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences.

Authors:  Leonardo Spatola; Claudio Angelini; Salvatore Badalamenti; Silvio Maringhini; Giovanni Gambaro
Journal:  Urolithiasis       Date:  2016-12-05       Impact factor: 3.436

5.  A prospective evaluation of obesometric parameters associated with renal stone recurrence.

Authors:  Derek Bos; Shawn Dason; Edward Matsumoto; Jehonathan Pinthus; Christopher Allard
Journal:  Can Urol Assoc J       Date:  2016-08       Impact factor: 1.862

6.  Metabolic disorders: stones as first clinical manifestation of significant diseases.

Authors:  Jean-Philippe Haymann
Journal:  World J Urol       Date:  2014-09-05       Impact factor: 4.226

Review 7.  Role of insulin resistance in uric acid nephrolithiasis.

Authors:  Hanhan Li; Dane E Klett; Raymond Littleton; Jack S Elder; Jesse D Sammon
Journal:  World J Nephrol       Date:  2014-11-06

8.  Are stone analysis results different with repeated sampling?

Authors:  Terence T N Lee; Mohamed A Elkoushy; Sero Andonian
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

9.  Shock wave lithotripsy does not impair renal function in a Swine model of metabolic syndrome.

Authors:  Rajash K Handa; Cynthia D Johnson; Bret A Connors; Andrew P Evan; Carrie L Phillips; Ziyue Liu
Journal:  J Endourol       Date:  2014-11-18       Impact factor: 2.942

10.  Visceral obesity: A new risk factor for stone disease.

Authors:  Ilker Akarken; Hüseyin Tarhan; Rahmi Gökhan Ekin; Özgür Çakmak; Gökan Koç; Yusuf Özlem İlbey; Ferruh Zorlu
Journal:  Can Urol Assoc J       Date:  2015-11-04       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.